Sun Pharmaceutical Industries Share Price Today - Live Blog for August 14, 2025

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.21%, signalling a challenging period. Currently trading at ₹1,636.95, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.05% decline and is currently trading at ₹1,641.50 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 0.11% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,642.60 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.09% in its share price, and it currently trades at ₹1,640.00 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

With a -0.08% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,642.50. The stock is currently trading at a PE of 37.9300, while the industry PE is 33.7711, prompting investors to assess its value proposition.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.09% slump and is currently trading at ₹1,642.05. While the stock maintains a PE ratio of 37.9300, the industry PE is 33.7711, raising questions about valuation.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.21% increase in its share price and is currently trading at ₹1,643.60. This remarkable performance has caught the eye of investors.

Sun Pharmaceutical Industries Ltd's stock price surged by 0.03%, reaching the current market value of ₹1,640.20 per share. This surge is a testament to the stock's recent performance.

The share price of Sun Pharmaceutical Industries Ltd experienced an uptrend, surging by 0.22% recently. As of now, this stock is actively trading at a current market price of ₹1,639.80 per share, attracting attention from investors.

Sun Pharmaceutical Industries Ltd experienced a -0.05% downturn in its share price, and it's currently trading at ₹1,634.30. This situation is generating interest among value investors who are evaluating the stock's potential.

Sun Pharmaceutical Industries Ltd witnessed a -0.20% drop in its share price and is currently trading at ₹1,634.10. With the stock's PE at 37.9300 and the industry PE at 33.7711, investors are weighing their options.

Demonstrating a commendable 0.03% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,637.40. In terms of valuation, the stock maintains a PE ratio of 37.9300, while the industry PE ratio stands at 33.7711.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.08% uptick in its share price. As a result, it's now actively trading at ₹1,636.85 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd observed a -0.09% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,635.55. The stock has a PE ratio of 37.9300, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.11%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,637.05, and market participants are assessing the implications. The stock has a PE ratio of 37.9300, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd shares saw a -0.02% decrease, reaching a current market price of ₹1,638.90. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 37.9300, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

After a notable 0.36% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,639.20. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

Sun Pharmaceutical Industries Ltd experienced a -0.02% dip in its share price and is currently trading at ₹1,633.25. The stock has a PE ratio of 37.9300, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd observed a -0.00% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,633.55. The stock has a PE ratio of 37.9300, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.13% decline, and it currently trades at ₹1,634.90 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a remarkable 0.08% increase in value, the share price of Sun Pharmaceutical Industries Ltd currently stands at ₹1,637.05. Notably, this stock has a Price-to-Earnings (PE) ratio of 37.9300, while the industry's PE ratio is 33.7711.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.13% slump and is currently trading at ₹1,636.00. While the stock maintains a PE ratio of 37.9300, the industry PE is 33.7711, raising questions about valuation.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.26% drop, and it's now trading at ₹1,639.55 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.18%, with its current market value per share resting at ₹1,647.70. This development highlights the stock's appeal to investors.

With a -0.20% decrease, Sun Pharmaceutical Industries Ltd's share price is now ₹1,645.65. Investors should examine the factors driving this decline. The stock's PE ratio is 37.9300, whereas the industry PE ratio stands at 33.7711.

In a noteworthy development, Sun Pharmaceutical Industries Ltd witnessed a remarkable 1.12% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,650.45 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.